Cost-utility analysis of add-on vericiguat for the treatment of chronic heart failure with reduced ejection fraction in China

• Main Authors: Lu Wang (Author), Xuechen Huo (Author), Haiyan Sun (Author), Feiyu Liu (Author), Ruiqin Huang (Author), Quan Zhao (Author)
• Format: Book
• Published: BMC, 2024-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Objective This study aimed to evaluate the cost-utility of the addition of vericiguat for treating chronic heart failure (CHF) in China from the healthcare payer's perspective. Methods A Markov model was built to estimate the cost and utility of treating CHF using vericiguat plus stand...